Newswire Editor is a Common Dreams staff position.
In an interview with Danish national public radio broadcast station DR, Bavarian Nordic CFO Henrik Juuel reacted to public calls for the company to lower the price of its mpox vaccine. In late August, Public Citizen sent a letter to CEO Paul Chaplin urging Bavarian Nordic to prioritize public health amid the global mpox emergency and lower the price of Jynneos, the biotech company’s mpox shot.
Previous Public Citizen research found multiple global manufacturers in low- and middle-income countries using similar manufacturing processes as Bavarian Nordic’s selling vaccines for $4 or less per dose – a fraction of the estimated price of Jynneos. Public Citizen Access to Medicines director Peter Maybarduk says despite push back, we must hold companies like Bavarian Nordic accountable for unfair pricing.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bavarian Nordic shares pop over 11% on earnings beat, bumper mpox vaccine orderShares of Danish biotech company Bavarian Nordic jumped in early deals Thursday after reporting first-half earnings and a bumper mpox vaccine order.
Read more »
Bavarian Nordic shares pop over 13% on earnings beat, bumper mpox vaccine orderShares of Danish biotech company Bavarian Nordic jumped Thursday after reporting first-half earnings and a bumper mpox vaccine order.
Read more »
Mpox Vaccine Maker Bavarian Nordic Shares Soar Amid Concern Over Virus OutbreakRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Mpox Vaccine Maker Bavarian Nordic Shares Soar Amid Concern Over Virus OutbreakRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergencyCEO Paul Chaplin told CNBC that the expanded approval for 12 to 17 year-olds would be crucial in tackling the latest outbreak.
Read more »
Stocks making the biggest moves midday: Rocket Lab, Bavarian Nordic, H&R Block and moreThese are the stocks posting the largest moves in midday trading.
Read more »